Pyne D, Isenberg D A
Centre for Rheumatology, University College London, Arthur Stanley House, 4th Floor, 40-50 Tottenham Street, London W1P 9PJ, UK.
Ann Rheum Dis. 2002 Jan;61(1):70-2. doi: 10.1136/ard.61.1.70.
The reported prevalence of autoimmune thyroid disease (3.9-24%) and antithyroid antibodies (11-51%) in SLE varies considerably. Early reports were mainly based on short term studies of small cohorts.
To report the prevalence of autoimmune thyroid disease and thyroid antibodies in 300 patients with SLE, followed up at our centre between 1978 and 2000, by a retrospective analysis of case notes.
The prevalence (5.7%) of hypothyroidism in our cohort was higher than in the normal population (1%), while that of hyperthyroidism (1.7%) was not significantly different. Overall 42/300 (14%) of our cohort had thyroid antibodies, rising to 15/22 (68%) in the subgroup who also had thyroid disease (p<0.001). Both antimicrosomal and antithyroglobulin antibodies were detected. The antibodies were found in equally high frequency in the hyperthyroid subgroup (80% patients), whereas in the hypothyroid subgroup antimicrosomal antibodies were more frequent than antithyroglobulin antibodies (64% v 41%). There was no significant difference in the frequency with which antimicrosomal or antithyroglobulin antibodies were detected between the hyperthyroid and hypothyroid subgroups (p>0.2).
Our patients with SLE had a prevalence of hypothyroidism, but not hyperthyroidism, greater than that of the normal population. The presence of either condition was associated with a higher frequency of both antimicrosomal and antithyroglobulin antibodies.
系统性红斑狼疮(SLE)患者中自身免疫性甲状腺疾病的报告患病率(3.9 - 24%)和抗甲状腺抗体的报告患病率(11 - 51%)差异很大。早期报告主要基于对小队列的短期研究。
通过对病例记录的回顾性分析,报告1978年至2000年间在我们中心随访的300例SLE患者中自身免疫性甲状腺疾病和甲状腺抗体的患病率。
我们队列中甲状腺功能减退症的患病率(5.7%)高于正常人群(1%),而甲状腺功能亢进症的患病率(1.7%)无显著差异。我们队列中总体有42/300(14%)的患者有甲状腺抗体,在同时患有甲状腺疾病的亚组中这一比例升至15/22(68%)(p<0.001)。抗微粒体抗体和抗甲状腺球蛋白抗体均被检测到。在甲状腺功能亢进亚组中抗体的检出频率同样很高(80%的患者),而在甲状腺功能减退亚组中抗微粒体抗体比抗甲状腺球蛋白抗体更常见(64%对41%)。甲状腺功能亢进和甲状腺功能减退亚组之间抗微粒体或抗甲状腺球蛋白抗体的检测频率无显著差异(p>0.2)。
我们的SLE患者中甲状腺功能减退症的患病率高于正常人群,而甲状腺功能亢进症并非如此。这两种情况的存在均与抗微粒体抗体和抗甲状腺球蛋白抗体的较高频率相关。